Clinical Trials Logo

Clinical Trial Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348(3)


Clinical Trial Description

An open label, randomized, single dose, 2-sequence, 4-period, cross-over clinical trial to evaluate the pharmacokinetics and tolerability of CKD-348(3) with coadministration of CKD-828, D097 and D337 in healthy adult volunteers ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05192356
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact JaeWoo Kim, M.D., Ph.D.
Phone +82 10 6787 3806
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date January 26, 2022
Completion date April 16, 2022

See also
  Status Clinical Trial Phase
Completed NCT04587206 - A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 Phase 1
Completed NCT02933658 - Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers Phase 1
Recruiting NCT04883658 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) Phase 1
Completed NCT04673864 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 Phase 1
Completed NCT04694989 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) Phase 1
Not yet recruiting NCT04660370 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 Phase 1
Not yet recruiting NCT04987970 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg Phase 1
Recruiting NCT04554953 - A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia